Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleLaboratory Study

Characterization of Iodovinylmisonidazole as a Marker for Myocardial Hypoxia

Gary V. Martin, Joseph E. Biskupiak, James H. Caldwell, Janet S. Rasey and Kenneth A. Krohn
Journal of Nuclear Medicine June 1993, 34 (6) 918-924;
Gary V. Martin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph E. Biskupiak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James H. Caldwell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet S. Rasey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth A. Krohn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 34, Issue 6
June 1, 1993
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Characterization of Iodovinylmisonidazole as a Marker for Myocardial Hypoxia
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Characterization of Iodovinylmisonidazole as a Marker for Myocardial Hypoxia
Gary V. Martin, Joseph E. Biskupiak, James H. Caldwell, Janet S. Rasey, Kenneth A. Krohn
Journal of Nuclear Medicine Jun 1993, 34 (6) 918-924;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Characterization of Iodovinylmisonidazole as a Marker for Myocardial Hypoxia
Gary V. Martin, Joseph E. Biskupiak, James H. Caldwell, Janet S. Rasey, Kenneth A. Krohn
Journal of Nuclear Medicine Jun 1993, 34 (6) 918-924;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Molecular Targeting with Radionuclides: State of the Science
  • 99mTc-HL91 : "Hot Spot" Detection of Ischemic Myocardium In Vivo by Gamma Camera Imaging
  • 99mTc-HL91 : Effects of Low Flow and Hypoxia on a New Ischemia-Avid Myocardial Imaging Agent
  • Myocardial Adaptation During and After Sustained, Demand-Induced Ischemia: Observations in Closed-Chest, Domestic Swine
  • Myocardial Kinetics of a Putative Hypoxic Tissue Marker, 99mTc-Labeled Nitroimidazole (BMS-181321), After Regional Ischemia and Reperfusion
  • Google Scholar

More in this TOC Section

  • [Methyl-Carbon-11]Thymidine for In Vivo Measurement of Cell Proliferation
  • Enhancement of Radiation Dose to the Nucleus by Vesicular Internalization of Iodine-125-Labeled A33 Monoclonal Antibody
  • Tumor-Selective Radiopharmaceutical Targeting via Receptor-Mediated Endocytosis of Gallium-67-Deferoxamine-Folate
Show more Laboratory Study

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire